Early research (Phase 1)Active Not RecruitingNCT05238922What this trial is testingStudy of INCB123667 in Subjects With Advanced Solid TumorsWho this might be right forSolid Tumors Incyte Corporation 291
Testing effectiveness (Phase 2)Study completedNCT00006357What this trial is testingSTI571 in Treating Patients With Recurrent or Refractory Soft Tissue SarcomaWho this might be right forEndometrial CancerGastrointestinal Stromal TumorOvarian Cancer+2 more European Organisation for Research and Treatment of Cancer - EORTC 91
Testing effectiveness (Phase 2)Study completedNCT00390234What this trial is testingZiv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue SarcomaWho this might be right forFallopian Tube CancerFemale Reproductive CancerOvarian Carcinosarcoma+9 more National Cancer Institute (NCI) 63
Testing effectiveness (Phase 2)Study completedNCT00245102What this trial is testingSorafenib in Treating Patients With Metastatic, Locally Advanced, or Recurrent SarcomaWho this might be right forAdult AngiosarcomaAdult Epithelioid SarcomaAdult Leiomyosarcoma+12 more National Cancer Institute (NCI) 147
Early research (Phase 1)Study completedNCT00413322What this trial is testingStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid TumorsWho this might be right forTumor Valerio Therapeutics 35
Early research (Phase 1)Active Not RecruitingNCT05691504What this trial is testingTesting the Combination of APG-1252 (Pelcitoclax) and Cobimetinib in Recurrent Ovarian and Endometrial CancersWho this might be right forAdvanced Endometrial CarcinomaMetastatic Endometrial CarcinomaMetastatic Fallopian Tube Carcinoma+8 more National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT03648489What this trial is testingDual mTorc Inhibition in advanCed/Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Cancer (of Clear Cell, Endometrioid and High Grade Serous Type, and Carcinosarcoma)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinosarcoma+7 more Imperial College London 134
Testing effectiveness (Phase 2)Active Not RecruitingNCT05920798What this trial is testingVaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity CancerWho this might be right forFallopian Tube CarcinosarcomaPrimary Peritoneal CarcinosarcomaRecurrent Fallopian Tube Carcinoma+13 more Mayo Clinic 38
Testing effectiveness (Phase 2)Study completedNCT00003939What this trial is testingEcteinascidin 743 in Treating Patients With Advanced Soft Tissue SarcomaWho this might be right forBrain and Central Nervous System TumorsEndometrial CancerGastrointestinal Stromal Tumor+3 more European Organisation for Research and Treatment of Cancer - EORTC 132
Testing effectiveness (Phase 2)Looking for participantsNCT06639074What this trial is testingFolate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT TrialWho this might be right forAdvanced Fallopian Tube CarcinomaAdvanced Fallopian Tube High Grade Serous AdenocarcinomaAdvanced Ovarian Carcinoma+15 more Mayo Clinic 78
Testing effectiveness (Phase 2)Study completedNCT01010126What this trial is testingTemsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerWho this might be right forAdult Hepatocellular CarcinomaAdvanced Adult Hepatocellular CarcinomaEndometrial Serous Adenocarcinoma+42 more National Cancer Institute (NCI) 252
Early research (Phase 1)Study completedNCT02020707What this trial is testingNab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological CancersWho this might be right forCervical AdenocarcinomaCervical AdenosarcomaCervical Adenosquamous Carcinoma+45 more Mayo Clinic 43
Testing effectiveness (Phase 2)Ended earlyNCT03601897What this trial is testingA Phase 1b/2 Study of Rebastinib (DCC-2036) in Combination With Paclitaxel in Patients With Advanced or Metastatic Solid TumorsWho this might be right forLocally Advanced or Metastatic Solid Tumor Deciphera Pharmaceuticals, LLC 177
Testing effectiveness (Phase 2)Ended earlyNCT05001282What this trial is testingEvaluate ELU001 in Patients With Solid Tumors That Overexpress Folate Receptor Alpha (FRα)Who this might be right forOvarian CancerOvarian NeoplasmsOvarian Carcinoma+22 more Elucida Oncology 79
Early research (Phase 1)Study completedNCT00006981What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced CancerWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00474994What this trial is testingSunitinib in Treating Patients With Metastatic, Locally Advanced, or Locally Recurrent SarcomasWho this might be right forAdult Malignant Fibrous Histiocytoma of BoneDesmoid TumorEndometrial Cancer+3 more Memorial Sloan Kettering Cancer Center 53
Early research (Phase 1)Ended earlyNCT05252416What this trial is testing(VELA) Study of BLU-222 in Advanced Solid TumorsWho this might be right forAdvanced Solid TumorsHR+ Breast CancerCCNE1 Amplification+6 more Blueprint Medicines Corporation 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT05147558What this trial is testingPembrolizumab With Lenvatinib in Women With Advanced Uterine CarcinosarcomaWho this might be right forUterine CarcinosarcomaAdvanced Uterine Carcinosarcoma Memorial Sloan Kettering Cancer Center 40
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Ended earlyNCT04171700What this trial is testingEvaluate Rucaparib in Participants With Solid Tumors and With Deleterious Mutations in HRR GenesWho this might be right forSolid Tumor pharmaand GmbH 83